Low levels of ventricular CSF orexin/hypocretin in advanced PD.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 12939433.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The origins of excessive daytime sleepiness in Parkinson disease (PD) are unclear. The authors hypothesize that orexin neurons, a recently identified wake promoting system, could contribute to its pathophysiology. They measured orexin-A/hypocretin-1 concentration in ventricular CSF in 19 parkinsonian patients and compared it with neurologic controls. Orexin levels were lower in patients and decreased with the severity of the disease. The authors suggest that orexin neurons contribute to daytime sleepiness in late stage PD.
Medical subject headings
- Disorders of Excessive Somnolence
- Intracellular Signaling Peptides and Proteins
- Neuropeptides
- Parkinson Disease